CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $593 | -30.8% | 27,152 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $857 | +15.2% | 26,945 | -11.6% | 0.00% | 0.0% |
| Q1 2023 | $744 | -42.7% | 30,487 | -26.0% | 0.00% | -50.0% |
| Q4 2022 | $1,299 | -99.9% | 41,171 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,163,000 | +15.7% | 41,152 | +8.3% | 0.00% | +100.0% |
| Q2 2022 | $1,005,000 | -5.7% | 38,006 | +24.8% | 0.00% | 0.0% |
| Q1 2022 | $1,066,000 | +15.2% | 30,454 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $925,000 | +23.2% | 28,526 | +12.0% | 0.00% | 0.0% |
| Q3 2021 | $751,000 | -3.0% | 25,467 | -15.7% | 0.00% | 0.0% |
| Q2 2021 | $774,000 | – | 30,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
| Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
| Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
| Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
| Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
| Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
| Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
| Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
| Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
| FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |